58 results

• Plans to Remove Potentially Carcinogenic Contaminants from Januvia, Janumet Outlined By Merck

  January 18, 2023

  Irvin Jackson

  Merck indicates it will remove nitrosamine contaminants from Januvia and Janumet by the end of 2023.

• Diabetes Drug Lawsuits Over Pancreatic Cancer Risk Dismissed, Again

  March 17, 2021

  Irvin Jackson

  A federal judge has again dismissed hundreds of diabetes drug lawsuits alleging medications like Byetta and Januvia can cause pancreatic cancer.

• Januvia Pancreatic Cancer Lawsuit To Be Decided By Jury, Illinois Appeals Court Determines

  January 2, 2019

  Austin Kirk

  An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.

• Byetta, Victoza and Januvia Lawsuits Over Pancreatic Cancer Mount in Reinstated Litigation

  June 8, 2018

  Austin Kirk

  A growing number of lawsuits over claims that Byetta, Victoza and similar diabetes drugs can cause pancreatic cancer are being filed in the wake of a recent decision to reinstate the litigation.

• Pancreatic Cancer Lawsuits Over Januvia, Byetta and Victoza Not Set For Bellwether Trials Until 2020

  March 28, 2018

  Irvin Jackson

  A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.

• Hundreds of Januvia, Victoza, Byetta Lawsuits Reinstated by Appeals Court Ruling

  December 14, 2017

  Austin Kirk

  More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.

• Diabetes Drug Pancreatic Cancer Lawsuits Dismissed on Preemption Grounds

  November 17, 2015

  Irvin Jackson

  A federal judge has granted summary judgment in the federal litigation over incretin mimetic diabetes drugs, which alleged that inadequate warnings were provided about the risk of pancreatic cancer from Byetta, Victoza, Januvia and Janumet.

• Some Diabetes Drugs May Increase Heart Disease Risks, Researcher Warns

  August 10, 2015

  Irvin Jackson

  Doctors should individualize diabetes drug treatments for patients with a high risk of heart disease, due to the varying levels of cardiovascular risk associated with certain diabetes drugs, according to one researcher.

• Summary Judgment Sought in Pancreatic Cancer Lawsuits Over Januvia, Janumet, Byetta, Victoza

  June 30, 2015

  Austin Kirk

  A federal judge has been asked to enter summary judgement in failure to warn lawsuits filed over the pancreatic cancer risk with Byetta, Januvia, Janumet and Victoza, arguing that the FDA would have any proposed warning update.

• Health Problems Linked to Invokana, Farxiga, Onglyza, Nesina in Adverse Event Reports

  June 29, 2015

  Irvin Jackson

  Some diabetes drugs unexpected linked to heart failure risks, new report finds.